Future Vision for Health Training Company (TADAWUL:9632)

Accolade Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	3.77	3.87	5.1
Depreciation & Amortization	0.86	0.57	0.32
Provision & Write-off of Bad Debts	0.04	0.04	-
Other Operating Activities	0.17	0.11	0.14
Change in Accounts Receivable	-2.67	-1.13	-2.61
Change in Other Net Operating Assets	1.4	-0.6	4.25
Operating Cash Flow	2.99	2.85	7.2
Operating Cash Flow Growth	-	-60.41%	-
Capital Expenditures	-2.22	-4.19	-0.02
Investing Cash Flow	-2.22	-4.19	-0.02
Long-Term Debt Repaid	-	-1.77	-1.1
Net Debt Issued (Repaid)	-1.69	-1.77	-1.1
Financing Cash Flow	-1.69	-1.77	-1.1
Miscellaneous Cash Flow Adjustments	-	-	0.04
Net Cash Flow	-0.93	-3.11	6.12
Free Cash Flow	0.77	-1.34	7.18
Free Cash Flow Margin	4.67%	-7.96%	52.97%
Free Cash Flow Per Share	0.17	-0.30	37.14
Cash Interest Paid	0.11	0.11	0.18
Levered Free Cash Flow	-	-2.8	-
Unlevered Free Cash Flow	-	-2.71	-
Change in Net Working Capital	-	1.7	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.